Dr. Jonathan Spicer is an associate professor of surgery at McGill University, where he is the medical director of the McGill University Health Center (MUHC) Thoracic Oncology Network. He chairs the McGill regional thoracic oncology tumor board and is co-director of the MUHC thoracic oncology clinical trials unit. Dr. Spicer is a surgeon scientist leading a broad research program covering basic, translational and clinical research topics. He trained in general surgery at McGill University and subsequently in cardiothoracic surgery at the University of Texas, MD Anderson Cancer Centre.
On a basic science front, Dr. Spicer is recognized as a leader in our understanding of how neutrophils impact cancer progression, and in particular, on the role of neutrophil extracellular traps in cancer biology. On a clinical front, Dr. Spicer has developed one of the most active research programs in the area of neoadjuvant therapy for operable lung cancer. He is an expert in surgical enhanced recovery protocols and his clinical practice is focused on minimal access techniques for pulmonary surgery and extended resections for thoracic malignancies. He is the program director for the McGill Advanced Thoracic and Upper GI Surgical Oncology Fellowship. Dr. Spicer currently plays an important leadership role in several international clinical trials investigating the role of novel therapeutics for patients with early-stage lung cancer.